Related Experiment Video
Updated: Jan 6, 2026

Stromal Vascular Fraction-enriched Fat Grafting for the Treatment of Symptomatic End-neuromata
Published on: November 23, 2017
Management of Lip Complications
1Department of Otolaryngology-Head and Neck Surgery, New York University School of Medicine, 550 First Avenue, NBV 5E5, New York, NY 10016, USA.
Learn about potential complications from lip injectable fillers and how to manage them. This article provides evidence-based guidelines for addressing adverse events following lip augmentation procedures.
Area of Science:
- Dermatology
- Plastic Surgery
- Aesthetic Medicine
Background:
- Lip augmentation procedures, particularly those using injectable fillers, are increasingly popular.
- Complications can arise following these aesthetic treatments.
- Prompt and accurate management is crucial for patient outcomes.
Purpose of the Study:
- To systematically review and present complications associated with lip injectable fillers.
- To provide evidence-based guidelines for the management of these complications.
Main Methods:
- Systematic review of literature on lip filler complications.
- Consolidation of evidence-based management strategies.
- Structured presentation of findings.
Main Results:
- Common complications include vascular compromise, infection, and inflammatory reactions.
- Less common complications involve granuloma formation and filler migration.
- Management strategies vary based on the specific complication and filler type.
Conclusions:
- Understanding potential lip filler complications is essential for practitioners.
- Adherence to evidence-based guidelines ensures optimal patient safety and treatment success.
- Effective management protocols can mitigate adverse events and improve aesthetic results.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Angina IV: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Acute Pancreatitis II: Clinical Manifestations and Management
Mitral Stenosis III: Medical Management
Atherosclerosis III: Management
